Compositions for Use in the Treatment of Neurological Disease
OwnerPaula MCCLEANinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions for use in the treatment of neurological disease. In one embodiment, the present invention relates to a peptide analogue of xenin or gastric inhibitory polypeptide for use in the treatment of neurological disorders. Also disclosed are methods of treatment of of neurological disease, and use of a peptide analogue according to the invention in the manufacture of a medicament for treating neurological disorders.
Claims22
A peptide analogue of xenin for use in the treatment of neurological disorders.
A peptide analogue of gastric inhibitory polypeptide, or a fragment thereof, for use in the treatment of neurological disorders.
A peptide analogue for use according to any preceding claim, wherein the peptide analogue further comprises at least one amino acid modification comprising attachment of a polymer moiety of the general formula HO—(CH2-O—CH2)n-H, wherein n is an integer between 1 and 22.
A composition for use in the treatment of neurological disorders, wherein the composition comprises a peptide analogue of xenin or a peptide analogue of gastric inhibitory polypeptide, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.